EA
AORT icon

Evolution Advisers’s Artivion AORT Stock Holding History

Evolution Advisers’s Portfolio AORT Stock Details AORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
+4
New +$112 ﹤0.01% 253

Other funds holding AORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Evolution Advisers's AORT Position: Q2 2026 in Review

Evolution Advisers opened a new position in Artivion (AORT) in Q2 2026: 4 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #253 among its holdings.

206 funds tracked by Wall St. Rank hold AORT as of Q2 2026.

  • Evolution Advisers held 4 shares of Artivion worth $0 as of Q2 2026.
  • Artivion was a new Evolution Advisers position in Q2 2026.
  • Artivion made up ﹤0.01% of Evolution Advisers's portfolio in Q2 2026, its #253 holding.
  • 206 funds tracked by Wall St. Rank held Artivion as of Q2 2026.

Based on Evolution Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.